Antimycotics for Systemic Use
- Name
- Antimycotics for Systemic Use
- Accession Number
- DBCAT002194
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Anidulafungin An antifungal used in the treatment of several types of candida infections. Caspofungin An echinocandin used to treat a variety of fungal infections. Voriconazole A triazole compound used to treat fungal infections. Ketoconazole A broad spectrum antifungal used to treat seborrheic dermatitis and fungal skin infections. Flucytosine An antifungal indicated only to treat severe infections throughout the body caused by susceptible strains of Candida or Cryptococcus. Micafungin An antifungal agent used for the treatment of candidemia, acute disseminated candidiasis, and certain other invasive Candida infections, and for the prophylaxis of Candida infections during stem cell transplantation. Itraconazole A triazole antifungal agent used to treat various fungal infections, such as blastomycosis and onychomycosis. Posaconazole A triazole antifungal drug that is used to treat invasive infections by Candida species and Aspergillus species in severely immunocompromised patients. Isavuconazole Indicated for patients 18 years of age and older for the treatment of invasive aspergillosis [FDA Label]. Indicated for patients 18 years of age and older for the treatment of... Fluconazole A triazole antifungal used to treat various fungal infections including candidiasis. Amphotericin B An antifungal used to treat fungal infections in neutropenic patients, cryptococcal meningitis in HIV infection, fungal infections, and leishmaniasis. Hachimycin Not Annotated Oteseconazole An azole antifungal used to prevent recurrent vulvovaginal candidiasis in females who are not of reproductive potential. Ibrexafungerp A triterpene antifungal indicated in the treatment of vulvovaginal candidiasis and prevention of recurrent vulvovaginal candidiasis in post-menarchal patients. - Drugs & Drug Targets